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Lymphocyte-derived cytokines induce sequential expression
of monocyte- and T cell-specific chemokines in human
mesangial cells
Miuo ScIiwAiz, HEINFRIED H. RADEKE, KlAus RESCH, and PETER UCIECHOWSKI
Institute of Clinical Molecular Pharmacology, Medical School, Hannover, Germany
Lymphocyte-derived cytokines induce sequential expression of mono-
cyte- and T cell-specific chemokines in human mesangial cells. Chemo-
kines are a family of small related proteins that play an important role in
the selective recruitment of different leukocyte populations to the sites of
inflammation. Human glomerular mesangial cells are potent producers of
a variety of chemokines. Here we examined the kinetics of mesangial cell
chemokine expression with focus on the C-C or 3 chemokines monocyte
chemoattractant protein-i (MCP-l), regulated upon activation, normal T
cell expressed and secreted (RANTES), macrophage inflammatory pro-
tein-la (MIP-1 a), and the C-X-C or a chemokine interleukin-8 (IL-8) in
response to lymphocyte- or monocyte-derived cytokines and mesangial
cell growth factors. It was found that interferon-y (IFN-y), a cytokine
produced by THI lymphocytes, synergized with tumor necrosis factor-a(TNF-a) in RAJ'4TES expression and with IL-l$ in MCP-l synthesis.
Time course studies revealed an early peak of mRNA expression of
monocyte-specific MCP-1 upon activation with TNF-a in contrast to T
cell-specific RANTES, which reached the highest mRNA level after 18
hours. This sequence of TNF-a-induced MCP-1 and RANTES expression
was confirmed on the protein level. As another T-lymphocyte specific
chemokine, MIP-la mRNA and protein was expressed only in response to
TNF-a plus IFN-y with kinetics similar to those of RANTES expression.
Finally, unlike other mesangial growth factors basic fibroblast growth
factor (bFGF) induced MCP-l, RANTES, and IL-8 mRNA expression,
suggesting an involvement of autocrine regulation mechanisms in mesan-
gial chemokine expression.
Leukocyte migration from blood circulation into the tissue is an
essential component of the complex inflammation process and
includes chemoattraction, endothelial adhesion, and transendo-
thelial migration. It is well known that the infiltration of different
leukocyte populations is a common feature of the various forms of
glomerular disease. The mechanisms of recruitment of leukocytes
into the glomerulus are not precisely known. In vivo studies in
rodents stressed the involvement of local intrinsic cells in the
synthesis of chemoattractants [1—3], and there is good evidence
that mesangial cell-derived chemoattractive factors, after induc-
tion through pro-inflammatory mediators, such as bacterial lipo-
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polysaccharides (LPS), interleukin-1 (IL-I) and tumor necrosis
factor alpha (TNF-a), are involved in mediating renal pathology
[4—6]. Mesangial cells, characterized as specialized pericytes of
mesenchymal origin, share many properties of vascular smooth
muscle cells as well as macrophages. They seem to participate in
the majority of forms of glomerulonephritis, acting as inflamma-
tory cells by generating nitrite and oxygen radicals [7], prostaglan-
dins [8, 9], and extracellular matrix components [101 or by
up-regulating the expression of surface molecules, especially Fe
receptors for IgG [11], MHC class II and adhesion proteins [121.
When activated, mesangial cells respond by releasing growth
factors, such as basic fibroblast growth factor (bFGF) [13],
platelet-derived growth factor (PDGF) [14], GM-CSF, cytokines
like IL-i, IL-6, and chemokines [6]. The latter proteins participate
in acute and chronic inflammatory processes as well as in auto-
immune diseases because of their potential to selectively recruit
leukocyte subpopulations to sites of inflammation during the
initiation and exacerbation phase of an immune response, and
they also contribute to leukocyte activation in situ.
The low molecular weight chemokines (molecular wt 8 to 10
kDa) are structurally related but divided into three subfamilies,
C-X-C or a, C-C or p, and C chemokines, and characterized by
conserved cysteine residues [15]. In humans one important C-X-C
chemokine is IL-8, primarily acting on neutrophilic granulocytes.
The C-C chemokines including monocyte chemoattractant pro-
tein (MCP)-1, -2, and -3, macrophage inflammatory protein
(MIP)-la, MIP-lp, and RANTES, preferentially mediate chemo•
taxis to mononuclear cells. RANTES, MIP-ls, and MIP-113 have
been described to be chemotatic for T lymphocytes [16—18], and
these chemokines, besides their chemotactic properties, are re-
ported to regulate T cell adherence to endothelial adhesion
molecules (ICAM-1, VCAM-i) and extracellular matrix proteins
(fibronectin, collagen, laminin) [19]. Furthermore, RANTES has
been shown to directly activate T lymphocytes without involve-
ment of T cell antigen receptor signaling [20]. Other chemokines
with specificity for T cells are lymphotactin [21], interferon-
inducible protein-lO (IP-lO) [221, and monokine induced by
interferon gamma (MIG) [23]. Thus, there is increasing knowl-
edge about chemotactic factors guiding T lymphocytes to inflamed
tissues, where these cells may contribute to advanced inflamma-
tory processes.
In this study we investigated the sequential expression of
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chemokines with specificities for mononuclear leukocyte popula-
tions in cultured human mesangial cells (HMC). Based on the fact
that most animal models in renal pathology are models of acute
glomerulonephritis, these studies have focused on neutrophil
chemoattractants, as they are essential for these models. Human
kidney disease, however, is characterized by a chronic, relapsing
process, and the majority of investigations demonstrated the
involvement of mononuclear immune cells, especially monocytes
and IL-2R-expressing T cells [241 in phases of exacerbation.
Therefore, examining chemokine regulation in human mesangial
cells for the first time in detail, we put our emphasis on the C-C
group of chemokines and the mononuclear factors responsible for
their induction. The results we obtained revealed different kinet-
ics in the expression of monocyte- or T cell-specific chemokines,
suggesting differential leukocyte migration during the progression
of a glomerular inflammatory response. Furthermore, lympho-
cyte-derived cytokines seem to be of particular relevance in the
induction of T cell-specific chemokines, and also autocrine mes-
angial growth factors seem to participate in the regulation of
glomerular chemokine expression.
METHODS
Materials
Recombinant human (rh) IFN-y (2 >< io U/mg) was kindly
donated by Dr. B. Otto, Fraunhofer Institute, Hannover, Ger-
many; rhIL-1J3 (2 X iO U/mg) was a gift from Dr. H. Gallati
(Hoffmann-LaRoche, Basel, Switzerland); cDNAs for MCP-1,
RANTES, and MIP-In were donated by Dr. T. Schall (DNAX,
Palo Alto, CA, USA); TL-8 specific primers were a gift from Dr. S.
Wagner, (Dept. of Gastroenterology, Medical School, Hannover,
Germany); GAPDH cDNA was donated by Dr. B. Hipskind
(Dept. of Molecular Biology, Medical School, Hannover).
rhTNF-a (4 x 106 U/mg) was obtained from Phillips (Bissendorf,
Germany). Restriction enzymes and corresponding buffers used
for cDNA probe preparation were either from AGS (Heidelberg,
Germany) or from Boehringer (Mannheim, Germany). Phos-
phate-buffered saline (PBS), MCDB-302 medium, insulin (bo-
vine), and transferrin (human) were obtained from Sigma Chem-
ical Co. (Deisenhofen, Germany). RPMI 1640, non-essential
amino acids, L-glutamine, sodium pyruvate, mycoplasma-free
fetal calf serum (FCS, 20019), trypsin-EDTA (T/E) all were from
GIBCO BRL (Eggenstein, Germany). Cell culture plastic mate-
rial was from Nunc (Wiesbaden, Germany). All other materials
were obtained commercially at the highest quality available.
Human glomerular mesangial cell preparation and
characterization
For the present experimental series, selected tumor-free,
healthy tissue of kidneys from different donors undergoing tumor
nephrectomy (who had given their informed consent) were ob-
tained freshly with the help of the Department of Urology,
Medical School Hannover. Human mesangial cells were prepared
as described [7, 111. The different specimen showed no significant
differences in growth, proliferation and morphology. Character-
ization by immunofluorescence staining showed a positive reac-
tion with SMC-rnyosin and actin, vimentin, fibronectin, desmin
and collagen type IV, a negative reaction with anti-human keratin,
factor VIII and MHC class II antigen antisera. There was no
morphological evidence of the presence of macrophages (pseu-
dopodia), endothelial- or epithelial-like cells (cobblestone) or
fibroblasts. Additionally, by means of biochemical characteriza-
tion bone marrow-derived resident macrophages and endothelial
cells could be effectively disclosed by the following criteria: HMC
were MHC class II negative [251, showed a typical profile of
prostanoids [8, 9], and in contrast to macrophages did not express
5-lipoxygenase mRNA or produce leukotrienes [8], and unacti-
vated HMC released no reactive oxygen species [7, 26]. Further-
more, the use of HMC after passage number three excluded
macrophage as well as endothelial cell contaminations, as these
cell types do not survive multiple passaging under the described
medium conditions.
Culture conditions and stimulation of human mesangial cells
After the third passage HMC were grown, as described [7, 261,
in culture medium supporting cell proliferation, consisting of
RPMI-1640, NEA (I ml/dl), L-glutamine (2 mM), sodium pyru-
vate (2 mM), transferrin (5 ig/ml), insulin (125 U/ml) and FCS
(10%). For passage HMC were detached by T/E (0.125%/0.01%,
wt/vol) and split into 1:3. Serum-free culture of HMC was
performed using MCDB-302 supplemented as culture medium
without any FCS, leading to a growth arrest of HMC after 48
hours [9, 271. At this time point the resting medium was removed,
cells washed twice with PBS, and cultivated for various stimulation
periods in resting medium alone (control) or with the addition of
(if not otherwise indicated) 500 U/mI TNF-a, 500 U/rn IFN-y, 10
ng/ml IL-113, 10 ng/ml bFGF, or 10 ng/ml PDGF. The stimulating
agents were applied alone or in combination as indicated in the
Results section.
Ribonucleic acid preparation
Total cellular RNA was prepared from HMC cultured under
resting, serum-free or proliferating (10% FCS culture medium)
conditions in the absence or presence of the respective stimuli by
a modification of Chomczynski's method [11] using the commer-
cial RNAclean system (AGS). To increase the purity of the RNA
samples we extended the basic method by an additional LiCl (4 M)
precipitation step [11]. RNA amounts were determined by UV
spectroscopy.
Reverse transcribed—polymerase chain reaction
To prepare a cDNA probe specific for IL-8, we used a reverse
transcribed—polymerase chain reaction (RT-PCR) protocol de-
scribed for the GeneAmpR RNA PCR Kit (Perkin Elmer Cetus).
One microgram of total RNA from PBMC was reverse tran-
scribed and amplification of the resulting cDNA was performed in
a thermocycler Varius VR (Landgraf, Hannover, Germany) with
primer pairs specific for human IL-8 (sense: 5'-AAGGAAC-
CATCTCACTG; antisense: 5 '-GATTCTT'GGATACCACA-
GAG). PCR products were purified by phenol-chloroform extrac-
tion, and IL-8 eDNA was subsequently prepared using a
QiAquick® Gel Extraction Kit (QIAGEN, Hilden, Germany).
Northern blot analysis
Total cellular RNA from HMC was fractionated on 1% aga-
rose, 6% formaldehyde gels and transferred to Hybond N nylon
membranes (Amersham-Buchler, Braunschweig, Germany) by
capillary blotting with 10 x SSC (1 X SSC: 150 msi NaCI, 15 mM
Na-citrate, pH 7). After cross linking by UV irradiation the blots
were prehybridized for at least two hours at 42°C in 5 X SSPE, 5 x
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Denhardt's solution, 50% formamide, 5% dextransulfate, 0,5%
sodium dodecyl sulfate (SDS), and 400 jxg/ml denatured salmon
sperm DNA. The blots were hybridized overnight at 42°C in the
same solution containing heat-denatured 132P1-labeled cDNA
probes for RANTES, MCP-1, MIP-la, IL-8, GAPDH, or 13-
tubulin. Radioactive labeling of cDNAs was performed according
to standard protocols described elsewhere 28]. The filters were
subsequently washed twice in 2 X SSC at room temperature, once
for 15 minutes in 1 x SSC, 0,1% SDS at room temperature and
once for 15 minutes in 0.2 x SSC, 0.1% SDS at 62°C. Messages
were detected by autoradiography using Kodak X-OMAT AR
film; exposure time ranged from 3 to 72 hours at —70°C.
Semiquantitative analysis was employed by densitometric scan-
ning of the autoradiographs with the analytic Gel doc 1000 video
system from BlO-RAD Laboratories (Hercules, CA, USA).
Chemokine ELISA with mesangial cell supernatants
To obtain supernatants, HMC were grown in 24-well microtiter
plates under serum-free conditions in the presence of the respec-
tive stimulating agents for the indicated time periods. Superna-
tants were collected, and subsequent ELISA analysis was per-
formed using Quantikine Immunoassays for human MCP-1,
RANTES and MIP-ltx purchased from R&D Systems.
RESULTS
Differential induction of C-X-C and C-C chemokines by
monocyte- and T cell-derived cytokines
To imitate more closely the in vivo situation where mesangial
cells do not proliferate we used serum-free cultivated, growth-
Fig. 1. Effects of different cytokine
combinations on chemokine mRNA expression
in human mesangial cells. HMC under resting
conditions were stimulated with IL-1f3 (10 ngl
ml), TNF-cr (500 U/mI), IFN-y (500 U/mI)
single or in combination. After 24 hours of
incubation, total cellular RNA was isolated,
equal amounts of RNA were loaded on a
formaldehyde-agarose gel and blotted onto
nylon membranes, as described in the Methods
section. After hybridizations with 32P-labeled
eDNAs specific for MCP-1, RANTES, and IL-8
the blots were stripped by boiling in 0.1% SDS
and rehybridized to a GAPDH eDNA. Blots
were exposed to Kodak X-OMAT AR film with
intensifying screens at —70°C. The numbers
represent the quantitation results determined
by densitometric measurement of chemokine/
GAPDH ratios analyzed by the BlO-RAD
Video gel doe 1000 system. All shown Northern
autoradiographs are representatives of 3 to 6
experiments.
arrested HMC in the present experiments. In a stimulation series
with cytokines and combinations thereof we examined chemokine
mRNA expression in our cellular system. As examples of C-X-C
chemokines IL-8 and of C-C chemokines MCP-1 and RANTES
were analyzed. In Northern blot analysis we found that the
combination of lL-1/3 and TNF-cs appeared to be the strongest
inducer of mRNA for the C-X-C chemokine IL-8, whereas
IFN-y+TNF-a synergistically induced mRNA expression of the
C-C chemokine RANTES upon stimulation for 24 hours (Fig. II).
Another finding was a synergistic enhancement of MCP-1 mRNA
synthesis by IFN-y together with IL-1J3, which was observed after
24 hours of treatment, hut was not found after three hours (Fig.
2). Here, the synergy between IL-113 and IFN-y was even more
evident than the observation shown in Figure 1, but the average
value of the synergistic increase of MCP-l mRNA by IL-1p plus
IFN-y was about a twofold enhancement compared to the added
values of the results of lL-113 or IFN-y alone. Thus, IFN-y
supported the effects of the potent stimulators of C-C chemokine
expression, JL-113 and TNF-a.
Sequential induction of C-X-C and C-C chemokines
In time course studies, we investigated the time-dependence in
the regulation of chemokine expression. Using TNF-a as stimu-
lating agent, we observed an early peak of IL-8 and MCP-1
mRNA synthesis, beginning immediately after treatment and
reaching a maximum after three hours. (Fig. 3). Contrary to this
finding, there was a late induction of RANTES mRNA expres-
sion, which was first detectable after three hours and peaked at 18
hours. Examining the TNF--induced secretion of MCP-l and
0 . . 2.8 MCP-1/GAPDH
RANTES
0 0 . 0.5 RANTES/GAPDH
I L-8
. 0.2 IL-8/GAPDH
GAPDH
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RANTES into HMC supernatants, it was found that MCP-1
production increased rapidly to a level of about 2 ng/ml within
four hours, reaching an amount of 23.6 rig/mi after 36 hours. The
amounts of secreted RANTES were lower (—20 pg/mi after 4 hr)
but increased up to 4 ng/ml until 36 hours after treatment with
TNF-a (Fig. 4). This equals a 200-fold elevation of RANTES,
whereas MCP-I production only revealed a 12-fold enhancement
within the same time period.
Synergistic effects of IFN-y and inflammatory cytokines on
RANTES and MCP-1 expression
As mentioned before, costimulation of mesangial cells with
TNF-a and IFN-y resulted in a significant increase of RANTES
mRNA levels. A more detailed analysis using increasing concen-
trations of TNF-a combined with one concentration of IFN-y and
vice versa was performed. Our results demonstrate that the
addition of only one unit per ml IFN-y was sufficient to markedly
enhance RANTES mRNA accumulation in HMC stimulated with
500 U/mI TNF-cx. A saturation was reached using a concentration
of 100 U/mI IFN-y (Fig. 5A). These experiments were undertaken
at the time of maximal induction, that is, after 18 hours. On the
other hand, by adding increasing doses of TNF-a to IFN-y-
stimulated HMC, messages were found to accumulate until a
concentration of 1000 U/mI TNF-a, while a minimal dose of 10
U/mI TNF-a was necessary to synergize with IFN-y in elevating
RANTES mRNA expression. Comparing the kinetics of TNF-
a+IFN-y-induced RANTES mRNA synthesis with the effect of
TNF-a alone, there was no difference in the time course of
3 hrs 24 hrs
Control lhr 3hr 6hr l2hr l8hr 24hr 48hr
IFN-y IFN-y
Med IFN-y IL-ifI + IL-113 Med IFN-i lL-1f3 + IL-i 13
MCP-1
13-tub
0 1.9 2.9 5.2 0 2.5 3.0 13.5
Fig. 2. Synergism between IL-113 and IFN-y in MCP-1 mRNA expression. Growth-arrested HMC were treated with IL-113 (10 ng/ml), IFN-y (500
U/mi), and the combination of both. RNA preparation at 3 and 24 hours was followed by Northern hybridization to a labeled MCP-1 cDNA probe and
subsequent rehybridization to a f3-tubulin cDNA probe.
TNF-ct
MCP-1
RANTES
IL-8 Fig. 3. Sequential induction of MCP-1,
RANTES, and IL-8 mRNA expression by TNF-
a in HMC. Resting HMC were stimulated with
TNF-a (500 U/mI). Total cellular RNA was
prepared at different time points (1 to 48 hr),
GAPDH followed by Northern blot hybridization with
eDNA probes specific for MCP-1, RANTES,
IL-8, and GAPDH mRNA.
mRNA synthesis (Fig. 5B). On the level of the release of
chemokine proteins, however, the synergistic effects were less
evident than the Northern results. IFN-y alone did not induce
RANTES production (not shown), but in combination with
TNF-a a dose of 10 units IFN-y per ml increased RANTES
secretion over a period of 24 hours (Fig. 6A), although this
increase in protein was not as strong as expected from the
RANTES mRNA findings. Comparing the observed synergy
between IL-1!3 and IFN-y on MCP-1 mRNA expression, ELISA
analysis revealed an additive than a synergistic elevation of
MCP-1 secretion in response to IL-1f3 plus IFN-y, especially after
incubation times of 24 and 36 hours (Fig. 6B).
Expression of the C-C chemokine MIP-It in human mesangial
cells
We further examined the potential of HMC to express the C-C
chemokine MIP-l, which has been shown to be selectively
chemotactic for activated CD8 T cells and B lymphocytes. As
shown in Figure 7A, detectable amounts of MIP-ics mRNA were
found three hours after stimulation with TNF- and IFN-y and
reached a maximum at 18 hours, revealing a time course similar to
that of RANTES mRNA expression. TNF- or IFN-y alone, as
well as IL-1J3, GM-CSF, bacterial lipopolysaccharide, and combi-
nations other than TNF-x+IFN-y have been ineffective to induce
MIP-lcs mRNA in HMC. When using 20x concentrated super-
natants, a low but significant release of MIP-lo protein by
TNF-a+IFN-y-activated HMC was measured in a specific ELISA
(Fig. 7B), confirming the results revealed in Northern blot anal-
ysis.
Effects of bFGF and PGDF on the expression of chemokines by
human mesangial cells
DISCUSSION
The aim of our study was to examine the fine tuning of
regulation of chemokines produced by human mesangial cells. As
an intrinsic local cell, the resting mesangial cell is a model to test
the effects of inflammatory mediators or growth factors, which are
in part auto/paracrine substances released by HMC or produced
by renal bystander cells [10]. Because of their involvement in more
than two thirds of the forms of glomerulonephritis and their
location in the glomerulus, mesangial cells can easily get in
contact with soluble cytokines in the blood or with released
mediators from infiltrated leukocytes during inflammatory pro-
cesses in the kidney. In this context, we extended the studies of the
expression of chemotactic cytokines by mesangial cells in response
to pro-inflammatory mediators, focusing on the cooperative ef-
fects of these mediators and the sequential induction of different
chemokines.
This study shows that, besides the well-known effects of IL-i or
TNF-c, the addition of IFN-y to TNF-a or IL-I j3 contributed to
the expression of the C-C chemokines RANTES and MCP-1,
whereas the mRNA for the best-documented C-X-C chemokine
IL-8 was mostly synthesized after combined stimulation with
IL-113 and TNF-. In our time course experiments we have
demonstrated that there was a different chronological order in the
induction of chemokines attracting neutrophils and monocytes
with fast kinetics, and the expression of chemokines responsible
for the migration of lymphocytes that proceded with delayed
kinetics.
There is an expanding number of studies describing the expres-
sion of MCP-1 by mesangial cells. It is evident that MCP-1
mediates infiltration of monocytcs during renal diseases, and ii is
suggested to be mainly responsible for the monocyte chemotactic
activity generated by HMC [5, 6, 29. Besides immune complexes,
PDGF, low density lipoprotein (LDL), and thrombin are reported
to affect MCP-1 expression by HMC [30—33]. MCP-1 is the only
chemokine produced by HMC upon induction by IFN-y, and we
A
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Recently, we characterized bFGF as the main autocrine growth
factor for HMC, whereas PDGF was only weakly active [13]. With
respect to chemokine induction, bFGF was capable to induce
Time, hours IL-8, MCP-l, and RANTES mRNA expression after 18 hours,
while PDGF only marginally influenced MCP-1 and RANTES
B mRNA synthesis (Fig. 8A). In addition, combined stimulation of
bFGF and IL-113 led to a stronger accumulation of chemokine
mRNA as the combination of PDGF and IL-1j3, especially
concerning IL-8 mRNA. When RANTES secretion was mea-
sured, bFGF also proved to be more effective than PDGF,
including the combined application with IL-i j3 (Fig. 8B).
4 8 12 24 36
Time, hours
Fig. 4. TNF-a.induced MCP-1 and RANTES secretion into HMC super-
natants. ELTSA analysis of supernatants of growth-arrested HMC treated
with TNF-a (500 U/mI) for 4 to 36 hours. (A) MCP-1, (B) RANTES. All
ELISA results shown are representatives of 2 to 4 experiments.
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Fig. 5. Synergistic increase of TNF-a-induced
RANTES mRNA by IFN-y. (A) Resting HMC
were incubated with rising concentrations of
1FN-y added to 500 U/mI TNF-a, or with
increasing concentrations of TNF-o added to
500 U/mi IFN-y. Total cellular RNA was
prepared after 18 hours of stimulation with
subsequent Northern analysis specific for
RANTES mRNA. (B) Kinetic analysis of theRANTES/
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Fig. 6. Synergistic effects of IFN-y on RANTES and MCP-1 protein
secretion into supernatants of HMC cultures. (A) Growth-arrested cells
were treated with (1) 500 U/mi TNF-a, (2) 500 U/mi TNF-a+ 1 U/mi
IFN-y, (3) 500 U/mi TNF-a+ 10 U/mi IFN-y, (4) 500 U/mi TNF-a+ 100
U/mi IFN-y. Supernatants were coHected after 4 to 24 hours and assayed
for RANTES in a specific ELISA. (B) MCP-1 ELISA analysis of growth-
arrested HMC incubated with IL-lp (10 nglml), JFN-y (500 U/mi), or the
combination of both for 4 to 36 hours.
found that MCP-l is released in highest amounts after stimulation
with IL-i/3 plus IFN-y. As indicated, MCP-1 arid IL-8 mRNA
expression was found to be rapidly induced after mesangiai cell
activation with TNF-n, suggesting that these chemokines might be
involved in acute inflammation by mediating the influx of PMN
and monocytes. This is supported by the observation that MCP-1
expression is correlated with mesangial immune complex forma-
tion after 30 minutes, followed by a decline after 24 hours in the
rat anti-Thy-I modei [1].
Mesangial cells have recently been described to produce RAN-
TES, which is chemotactic for memory T cells, monocytes, and
eosiriophils, after treatment with LPS, IL-i and TNF-cs [34, 351
Interestingly, RANTES mRNA in HMC is not found to be rapidly
expressed in detectable amounts after activation, in contrast to
MCP-1 and IL-8. The role of RANTES in renal disease in vivo is
not clear at present. It might play a role in cell-mediated
transplant rejection, where transcripts were detected in infiltrating
mononuclear cells and renal tubular epithelium [36, 37]. In-
creased RANTES expression was also observed in rats with
accelerated nephrotoxic serum nephritis [38]. The mRNA expres-
sion of RANTES in HMC was only induced slowly with a delayed
peak at about 18 hours for mRNA expression. However, our data
demonstrated a marked synergistic effect revealing that minor
concentrations of IFN-y combined with TNF-a were sufficient to
enhance RANTES mRNA and protein synthesis in HMC. This
might reflect an in vivo situation, where low concentrations of T
cell lymphokines trigger HMC to release chemokine proteins.
Considering an increased mRNA stability as a possible explana-
tion of the IFN-y effect, we could not observe any change of
mRNA half life in IFN-y+TNF-a-treated HMC (not shown).
Additionally, IFN-y did not induce endogenous IL-la or IL-1f3 in
HMC (unpublished results). The mechanisms of the synergy
between TNF-a and IFN-y, which has already been described in
previous studies of various phenomena [39, 40], is likely to involve
postreceptor events on the transcriptional level, including gene
regulatory elements like activator protein-i (AP-1) and nuclear
factor K B (NFKB) as previously described for IL-8 [41]. This
assumption is strengthened by the finding of AP-i and NFKB
binding sites in the upstream region of the RANTES gene [42].
We also identified MIP-Ia as another C-C chemokine secreted
by HMC. MIP-la, which so far had not been described to be
expressed by mesangial cells, induces chemotaxis merely to eosin-
ophils, CD8 T cells, and B cells in Vitro [18, 19, 43]. MIP-la was
demonstrated to be required for an inflammatory response to viral
infections [44], to increase the adhesion of T lymphocytes to
endothelial cells [19] and up-regulate the expression of CD1Ib/
CDI8 and CD11c!CDI8 on monocytes [45]. Neutralization of
MIP-la inhibited the chemotactic activity found irs synovial fluids
of rheumatoid arthritis patients by 36% [46]. Our observation
strengthens the ability of intrinsic glomerular cells to produce
chemotactic peptides specifically attracting lymphocytes. Interest-
ingly, only TNF-a and IFN-y in combination induced mesangial
cell-derived MIP-icr mRNA and protein synthesis. Additionally,
the kinetics of induced transcription were similar to the time
course observed for RANTES production. The fact that TNF-a is
produced by monocytes and IFN-y is released by THI lymphocytes
suggests that T cells migrated inside the glomerulus might partic-
ipate in the induction of chemokines such as MCP-1, RANTES,
and MIP-la. In situations, where these surveilling memory T
helper cells encounter their specific antigen (such as that found in
the deposited antigen-containing immune complex in the glomer-
uli in rheumatoid arthritis), their initial IFN-y release together
with monocytic TNF-a leads to the attraction of a second wave of
naive and memory T cells by means of HMC-derived MCP-1,
RANTES, and MIP-la. At present it is difficult to say whether
this self-perpetuating event will occur in vivo and whether this
hypothetic process will lead to healing or chronic inflammation.
The experimental series performed with mesangial cell growth
factors revealed that bFGF and PDGF were weak inducers of
IL-8, MCP-1, and RANTES mRNA. In combination with lL-1f3,
bFGF acted synergistically only on IL-8 mRNA expression. In rat
mesangial cells, a synergistic elevation of MCP-1 transcripts
through PDGF and IL-I has recently been reported [471. On the
product level, only bFGF in combination with IL-113 led to a
higher RANTES production, whereas PDGF did not. These (lata
support our recent publication and unpublished results that bFGF
is predominantly responsible for mesangial cell proliferation in
humans and also for the release of prostaglandins, suggesting that
bFGF is not only an autocrine growth factor, but also involved in
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Fig. 7. Induction of MIP-la mRNA and protein expression in HMC by TNF-+IFN-y. (A) MIP-la-specific Northern analysis of RNA from
growth-arrested HMC activated with TNF-a+IFN-y (each 500 U/mI) for various time periods. (B) Concentrated supernatants (X20) were tested for
MIP-la after 12, 24, and 48 hours of culture in the presence of TNF-a+IFN-y (each 500 U/mI) measured in a specific ELISA. Because the presented
MIP-1 a concentrations were found using 20-fold concentrated supernatants, the values have to be devided by 20, resulting in 0.72 pg/mI at 12 hours,
1.21 pg/ml at 24 hours, and 1.46 pg/mI at 48 hours.
the initiation of the change from a resting into an activated
mesangial cell [13].
Our results support the assumption that the fine tuning of the
sequence of migrating immune cells is dependent on: (1) the type
and dose of cytokines that induce chemokines; (2) the combina-
tion of cytokines responsible for the amounts of chemokines; and
(3) on the time dependent induction of the different chemokines.
From these data we favor the hypothesis that the early induction
of IL-8 and MCP-1 by pro-inflammatory mediators such as IL-i,
TNF-a, or immune complexes first attracts PMN and monocytes
into the glomerulus. Besides the controversal findings that IL-8
and MCP-1 themselves are able to influence chemotaxis of T
lymphocytes, the later induction of RANTES and the additional
MIP-la expression may trigger the migration of T cell subpopu-
lations. T lymphocytes have been detected in glomerulonephritis
[48] and shown to be activated by MC [49], but their participita-
tion in glomerular diseases, for example, as local infiltrated cells,
has to be explained. Small numbers of activated, antigen-specific
T cells circulating with the blood stream through the glomerular
capillaries and migrating into the mesangium could be sufficient
to release IFN-y, which together with other cytokines initiates
infiltrative processes. Our data thereby offer a cooperative chain
of events to understand the phases of initiation and progression in
T cell-mediated, chronic human glomerulonephritis.
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APPENDIX
Abbreviations used in the article include: MPC-1, monocyte chemoat-
tractant protein-i; MIP-ics, macrophage inflammatory protein-la; IFN-y,
interferon-y; IL, interleukin; TNF-a, tumor necrosis factor-a; bFGF, basic
fibroblast growth factor; LPS, liposaccharides; MIG, monokine induced by
interferon gamma; HMC, human mesangial cells; FCS, fetal calf serum;
TIE, trypsin-EDTA; PBS, phosphate buffered saline; RT-PCR, reverse
transcribed polymerase chain reaction; PMN, polymorphonuclear; AP-i,
activator protein-i; NFKB, nuclear factor K B.
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